Jones Lang LaSalle Inc.
03/23/2026 | Press release | Distributed by Public on 03/23/2026 07:14
Siemens Healthineers selects JLL as FM service provider
CHICAGO, March 23, 2026 - JLL announced today that Siemens Healthineers, a global provider of healthcare equipment, solutions and services, selected it to provide integrated facilities management (IFM) services for 5.3 million square feet of office, R&D, lab and biomanufacturing space across 32 states and Canada.
JLL's specialized Life Sciences division is now responsible for the execution of facilities services, including building engineering; café services; electrical, elevator and HVAC maintenance; fire and life safety; janitorial, landscaping and grounds maintenance; and mail room, reception, waste disposal and recycling services. JLL delivers the services under an integrated model with strategic sourcing, finance and business intelligence functions to govern service delivery.
To increase efficiencies and provide Siemens Healthineers with added flexibility to meet rapidly changing business and commercial conditions, the JLL team is deploying a full suite of cutting-edge engineering programs and technology solutions. The approach will provide Siemens Healthineers with greater intelligence in their facility operations to optimize cost and improve resilience.
The JLL team leading IFM services includes Managing Director Pam Paddock and Account Executive Michael Lee, along with support from Executive Director of Solutions Development Joe Daufenbach.
"We are honored Siemens Healthineers selected us to provide end-to-end facilities management solutions that will enable operational efficiencies, create an exceptional workplace experience for their employees and align with their long-term strategy," Paddock said.
"Siemens recognized our extensive experience in the medical device industry and global alignment capabilities for seamless service delivery, and we are committed to providing them with innovative and quality services," added Kevin Wayer, Division President, Global - Life Sciences at JLL.
JLL's vision is to reimagine the world of real estate, creating, finding, locating and operating safe and amazing spaces. With persistent curiosity in advancing humanity, JLL's globally connected Life Sciences team of 3,600+ experienced professionals tailors unique strategies to help biotechnology, pharmaceutical, medical devices organizations, investors and developers turn science fiction into science fact. JLL brings deep understanding of location analytics, project management, research advisory, workplace experience, financial incentives, transaction management, capital markets, real estate strategy and technology, facilities management, regulatory compliance and quality, and more. Our solutions help fuel innovation, enhance efficiency, improve financial performance and attract and retain top talent. Our team is trained and certified to operate within office and critical environments of lab and manufacturing space. To learn more, visit jll.com/en-us/industries/life-sciences.
For more news, videos and research resources on JLL, please visit JLL's newsroom.
About JLL
JLL (NYSE:JLL) is a leading global commercial real estate services and investment management company with annual revenue of $26.1 billion, operations in over 80 countries and a global workforce of more than 113,000 as of December 31, 2025. For over 200 years, clients have trusted JLL, a Fortune 500® company, to help them confidently buy, build, occupy, manage and invest across a variety of industries and property types, including office, industrial, hotel, multi-family, retail and data center properties. Driven by our purpose to shape the future of real estate for a better world, we help our clients, people and communities SEE A BRIGHTER WAY. Powered by rich global datasets and leading technology capabilities, we provide coordinated, end-to-end delivery of real estate services for a broad range of global clients who represent a wide variety of industries. Through LaSalle Investment Management, we invest for clients on a global basis in both private assets and publicly traded real estate securities. For further information, visit jll.com.
About Siemens Healthineers
Siemens Healthineers pioneers breakthroughs in healthcare. For everyone. Everywhere. Sustainably. The company is a global provider of healthcare equipment, solutions and services, with activities in more than 180 countries and direct representation in more than 70. The group comprises Siemens Healthineers AG, listed as SHL in Frankfurt, Germany, and its subsidiaries. As a leading medical technology company, Siemens Healthineers is committed to improving access to healthcare for underserved communities worldwide and is striving to overcome the most threatening diseases. The company is principally active in the areas of imaging, diagnostics, cancer care and minimally invasive therapies, augmented by digital technology and artificial intelligence. In fiscal 2025, which ended on September 30, 2025, Siemens Healthineers had approximately 74,000 employees worldwide and generated revenue of around €23.4 billion. Further information is available at siemens-healthineers.com.
Jones Lang LaSalle Inc. published this content on March 23, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on March 23, 2026 at 13:14 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]